ArticleCell transplantation

What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?

Sara Bravaccini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.